SEARCH

SEARCH BY CITATION

References

  • 1
    DollR, PayneP, WaterhouseJ, eds. Cancer incidence in five continents: a technical report. Berlin: Springer-Verlag (for UICC), 1966.
  • 2
    DollR, MuirC, WaterhouseJ, eds. Cancer incidence in five continents, vol. II. Berlin: Springer-Verlag (for UICC), 1970.
  • 3
    WaterhouseJ, MuirC, CorreaP, PowellJ, eds. Cancer incidence in five continents, vol. III. Lyon: IARC Scientific Publications No. 15, IARC, 1976.
  • 4
    WaterhouseJ, MuirC, ShanmugaratnamK, PowellJ, eds. Cancer incidence in five continents, vol. IV. Lyon: IARC Scientific Publications No. 42, IARC, 1982.
  • 5
    MuirC, WaterhouseJ, MackT, PowellJ, WhelanS, eds. Cancer incidence in five continents, vol. V. Lyon: IARC Scientific Publications No. 88, IARC, 1987.
  • 6
    Parkin DM, Muir CS, Whelan SL, Gao Y-T, Ferlay J, Powell J. Cancer incidence in five continents, vol. VI. Lyon: IARC Scientific Publications No. 120, IARC, 1992.
  • 7
    Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents, vol. VII. Lyon: IARC Scientific Publications No. 143, IARC, 1997.
  • 8
    Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents, vol. VIII. Lyon: IARC Scientific Publications No. 155, IARC, 2002.
  • 9
    Curado MP, Edwards B, Shin HR, Ferlay J, Heanue M, Boyle P, Storm H. Cancer incidence five continents, vol. IX. Lyon: IARC Scientific Publications No. 160, IARC, 2007.
  • 10
    Ferlay J. Cancer incidence in five continents VII. CancerBase Series No. 2. Lyon: International Agency for Research on Cancer, 1997.
  • 11
    Ferlay J. Cancer incidence in five continents VIII. CancerBase Series No. 6. Lyon: International Agency for Research on Cancer, 2002.
  • 12
    Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer incidence in five continents, vol. I–VIII. IARC CancerBase Series No. 7. Lyon: International Agency for Research on Cancer, 2005.
  • 13
    WHO (World Health Organization). International statistical classification of diseases and related health problems. 10th revision. Geneva: WHO, 1993.
  • 14
    WHO (World Health Organization). Manual of the international statistical classification of diseases, injuries and causes of death (Based on the Recommendations of Seventh Revision Conference, 1955). Geneva: WHO, 1957.
  • 15
    WHO (World Health Organization). International classification of diseases for oncology, 2nd edn., (ICD-O). Geneva: WHO, 1990.
  • 16
    Quinn M, Babb P, Jones J, Allen, E. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ 1999; 318: 9048.
  • 17
    Nieminen P, Kallio M, Hakama M. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri. Obstet Gynecol 1995; 85: 101721.
  • 18
    Wang SS, Sherman ME, Hildesheim A, Lacey JV, Devesa S. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000. Cancer 2004; 100: 103544.
  • 19
    International Agency for Research on Cancer. Cervical cancer screening. IARC handbooks on cancer prevention, vol. 10. Lyon: IARC, 2005.
  • 20
    Colonna M, Guizard AV, Schvartz C, Velten M, Raverdy N, Molinie F, Delafosse P, Franc B, Grosclaude P. A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983–2000). Eur J Cancer 2007; 43: 891900.
  • 21
    Vizcaino AP, Moreno V, Lambert R, Parkin DM. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973–1995. Int J Cancer 2002; 99: 8608.
  • 22
    Wang H, Karesen H, Hervik A, Thoresen SO. Mammography screening in Norway: results from the first screening round and cost effectiveness of a modeled nationwide screening. Cancer Causes Control 2001; 12: 3945.
  • 23
    Hofvind S, Geller B, Vacek PM, Thoresen S, Skaane P. Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program. Eur J Epidemiol 2007; 22: 44755.
  • 24
    Tanaka H, Uera F, Tsukuma H, Ioka A, Oshima A. Distinctive change in male liver cancer incidence rate between the 1970s and 1990s in Japan: comparison with Japanese-Americans and US whites. Jpn J Clin Oncol 2007; 37: 1936.
  • 25
    Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R, EUROCARE Working Group. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer 2009; 45: 93191.
  • 26
    Sankaranarayanan R, Swaminathan R, Brenner H, Chen K, Chia KS, Chen JG, Law SC, Ahn YO, Xiang YB, Yeole BB, Shin HR, Shanta V, et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol 2010; 11: 16573.
  • 27
    Heasman MA, Lipworth L. Accuracy of certification of cause of death. Studies in Medical and Population Subjects 20. London: HMSO, 1966.
  • 28
    Percy C, Stanek E, Gloeckner L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 1981; 71: 24250.
  • 29
    Puffer RR, Wynne-Griffith G. Patterns of urban mortality. Pan American Health Organization Scientific Publication 151. Washington: PAHO WHO, 1967.
  • 30
    Boyle P. Relative value of incidence and mortality data in cancer research. Recent Results Cancer Res 1989; 114: 4163.
  • 31
    SankilaR, DemaretE, HakamaM, LyngeE, SchoutenL, ParkinDM, eds. Evaluation and monitoring of cancer screening programmes. Brussels-Luxembourg: European Commission, 2001.
  • 32
    Parkin DM. The evolution of the population-based cancer registry. Nat Rev Cancer 2006; 6: 60312.